Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus

Journal of the American Society of Nephrology

Volumn 10, Issue 9, 1999, Pages 1958-4964

  Van Lieburg, Angenita F ^a   Knoers, Nine V A M ^b   Monnens, Leo A H ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ARGIPRESSIN; DESMOPRESSIN; INDOMETACIN; VASOPRESSIN V2 RECEPTOR;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; FAILURE TO THRIVE; FEVER; FOLLOW UP; GENE MUTATION; HUMAN; HYDRONEPHROSIS; INFANT; MALE; NEPHROGENIC DIABETES INSIPIDUS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINE RETENTION; VOMITING;

EID: 0032803446     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Knoers NVAM, van den Ouweland AMW, Verdijk M, Monnens LAH, van Oost BA: Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 46: 170-176, 1994
2. Deen PMT, Verdijk MAJ, Knoers NVAM: Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95, 1994
3. van Lieburg AF, Verdijk MAJ, Knoers VVAM: Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water channel gene. Am J Hum Genet 55: 648-652, 1994
4. Bichet DG, Arthus M, Lonergan M: Autosomal dominant and autosomal recessive nephrogenic diabetes insipidus: Novel mutations in the AQP2 gene [Abstract]. J Am Soc Nephrol 6: 717A, 1995
5. Behrman RE, Vaughan VC: Nelson Textbook of Pediatrics, 11th Ed., Philadelphia, Saunders, 1979, pp 1347-1349
6. ten Bensel RW, Peters ER: Progressive hydronephrosis, hydroureter and dilation of the bladder in siblings with congenital nephrogenic diabetes insipidus. J Pediatr 77: 439-443, 1970
7. Wiggelinkhuizen J, Relief PJ, Wolff B, Cremin BJ: Nephrogenic diabetes insipidus and obstructive uropathy. Am J Dis Child 126: 398-401, 1973
8. Nakada T, Miyauchi T, Sumiya H, Shimazaki J: Nonobstructive urinary tract dilation in nephrogenic diabetes insipidus. Int Urol Nephrol 22: 419-427, 1990
9. Zender HO, Ruedin P, Moser F, Bolle JF, Leski M: Traumatic rupture of the urinary tract in a patient presenting nephrogenic diabetes insipidus associated with hydronephrosis and chronic renal failure: Case report and review of the literature. Clin Nephrol 38: 196-202, 1992
10. Holtzman EJ, Harris HW, Kolakowski LF, Guay-Woodford L, Botelho B, Ausiello DA: Brief report: A molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med 328: 1534-1537, 1993
11. Uribarri J, Kaskas M: Hereditary nephrogenic diabetes insipidus and bilateral nonobstructive hydronephrosis. Nephron 65: 346-349, 1993
12. Hoekstra JA, van Lieburg AF, Monnens LAH, Hulstijn-Dirkmaat GM, Knoers VVAM: Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61: 81-88, 1996
13. van Lieburg AF, Verdijk MAJ, Schoute F: Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 96: 70-78, 1995
14. Roede MJ, van Wieringen JC: Growth diagrams 1980: Netherlands third nationwide survey. Tijdschr Soc Gezondh 63[Suppl]: 1-34, 1985
15. Schaefer F, Burgard P, Batzler U: Growth and skeletal maturation in children with phenylketonuria. Acta Pediatr 83: 534-541, 1994
16. Monnens L, Smulders Y, van Lier H, De Boo T: DDAVP test for assessment of renal concentrating capacity in infants and children. Nephron 29: 151-154, 1981
17. Monnens L, Jonkman A, Thomas C: Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus. Clin Sci 66: 709-715, 1984
18. van Lieburg AF, Verdijk M, Knoers N: In vitro expression of mutations in the V2-receptor gene: Confirmation of their role in the pathogenesis of X-linked nephrogenic diabetes insipidus. Pediatr Nephrol 8: C75, 1994
19. Pan Y, Wilson P, Gitschier J: The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase, binding to vasopressin. J Biol Chem 269: 31933-31937, 1994
20. Yokoyama K, Yamauchi A, Izumi M: A low-affinity vasopressin V2 receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 7: 410-414, 1996
21. Knoers N, Monnens LAH: Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. Clin Lab Observ 117: 499-502, 1990
22. Niaudet P, Dechaux M, Leroy D, Broyer M: Nephrogenic diabetes insipidus in children. Front Horm Res 13: 224-231, 1985
23. Williams RH: Nephrogenic diabetes insipidus occurring in males and transmitted by females. J Clin Invest 25: 937-938, 1946
24. Caletti MG, Gimenez A, Lejarraga H: A longitudinal growth in height of 10 children with familiar nephrogenic diabetes insipidus (NDI). Congress of the International Pediatric Nephrology Association, Santiago, Chile, 1995, P132